Concepedia

Toru Mukohara

TM

Statistics

Publications

67

Citations

5.2K

H-Index

31

Active since

2001

Affiliations

National Cancer Center Hospital East(Current)

Kobe University

Kobe University Hospital

The Cancer Institute Hospital

Dana-Farber Cancer Institute

Toru Mukohara is an author at National Cancer Center Hospital East specializing in oncology, medicine, and molecular oncology.

ORCID

Publications per year

2001–2025

67

Publications

67

Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer

Yoshinori Imamura, Toru Mukohara, Yohei Shimono et al. · Oncology Reports · 2015 · 858 citations · Full text

, , +15

ErbB-3 mediates phosphoinositide 3-kinase activity in gefitinib-sensitive non-small cell lung cancer cell lines

Jeffrey A. Engelman, Pasi A. Jänne, Craig H. Mermel et al. · Proceedings of the National Academy of Sciences · 2005 · 489 citations · Full text

, , +15

Allelic dilution obscures detection of a biologically significant resistance mutation in EGFR-amplified lung cancer

J. A. Engelman, Toru Mukohara, Kreshnik Zejnullahu et al. · Journal of Clinical Investigation · 2006 · 457 citations · Full text

, , +17

Gefitinib Induces Apoptosis in the EGFRL858R Non–Small-Cell Lung Cancer Cell Line H3255

Sean Tracy, Toru Mukohara, Mark Berner Hansen et al. · Cancer Research · 2004 · 375 citations

, , +8

Differential Effects of Gefitinib and Cetuximab on Non–small-cell Lung Cancers Bearing Epidermal Growth Factor Receptor Mutations

Toru Mukohara, Jeffrey A. Engelman, Nasser H. Hanna et al. · JNCI Journal of the National Cancer Institute · 2005 · 317 citations

, , +17

1–5 of 67